How to interpret an overview: a meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.
作者信息
Easterbrook P J
机构信息
HIV Epidemiology Unit, Chelsea and Westminster Hospital, London, UK.
出版信息
Genitourin Med. 1997 Apr;73(2):139-43. doi: 10.1136/sti.73.2.139.
Abstract
摘要
相似文献
1
How to interpret an overview: a meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.如何解读一项综述：卡氏肺孢子虫预防方案相对疗效和毒性的荟萃分析
Genitourin Med. 1997 Apr;73(2):139-43. doi: 10.1136/sti.73.2.139.
2
Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.对人类免疫缺陷病毒（HIV）感染患者预防卡氏肺孢子虫肺炎和弓形虫性脑炎治疗方法的荟萃分析。
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 1;15(2):104-14. doi: 10.1097/00042560-199706010-00002.
3
Reasons for failure of prophylaxis for Pneumocystis carinii pneumonia.卡氏肺孢子虫肺炎预防失败的原因。
AIDS. 1999 May 28;13(8):991-2. doi: 10.1097/00002030-199905280-00017.
4
A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.卡氏肺孢子虫预防方案相对疗效和毒性的荟萃分析。
Arch Intern Med. 1996 Jan 22;156(2):177-88.
5
Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.甲氧苄啶-磺胺甲恶唑、氨苯砜和喷他脒预防卡氏肺孢子虫肺炎的比较。
Pharmacotherapy. 1996 Nov-Dec;16(6):1030-8.
6
Failure of intravenous pentamidine prophylaxis for Pneumocystis carinii pneumonia.
J Pediatr. 1993 Jan;122(1):163-4. doi: 10.1016/s0022-3476(05)83513-9.
7
Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
AIDS. 1994 Feb;8(2):272-4. doi: 10.1097/00002030-199402000-00021.
8
Aerosolized pentamidine prophylaxis of Pneumocystis carinii pneumonia.雾化戊烷脒预防卡氏肺孢子虫肺炎
Am J Med. 1995 Apr;98(4):422-3. doi: 10.1016/s0002-9343(99)80335-0.
9
Failure of trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis carinii pneumonia with concurrent leucovorin use.甲氧苄啶/磺胺甲恶唑预防卡氏肺孢子虫肺炎并同时使用亚叶酸的失败情况。
Infection. 2002 Jan;30(1):41-2. doi: 10.1007/s15010-001-1172-0.
10
Prevention and treatment of Pneumocystis carinii pneumonia in patients infected with HIV.
Drug Ther Bull. 1994 Feb 17;32(2):12-5. doi: 10.1136/dtb.1994.32212.
本文引用的文献
1
A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.卡氏肺孢子虫预防方案相对疗效和毒性的荟萃分析。
Arch Intern Med. 1996 Jan 22;156(2):177-88.
2
Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group.医学文献用户指南。II. 如何使用关于治疗或预防的文章。A. 研究结果是否有效？循证医学工作组。
JAMA. 1993 Dec 1;270(21):2598-601. doi: 10.1001/jama.270.21.2598.
3
Prophylaxis for opportunistic infections in patients with HIV infection.
Ann Intern Med. 1994 Jun 1;120(11):932-44. doi: 10.7326/0003-4819-120-11-199406010-00006.
4
Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group.医学文献用户指南。VI. 如何使用综述。循证医学工作组。
JAMA. 1994 Nov 2;272(17):1367-71. doi: 10.1001/jama.272.17.1367.
5
A method for assessing the quality of a randomized control trial.一种评估随机对照试验质量的方法。
Control Clin Trials. 1981 May;2(1):31-49. doi: 10.1016/0197-2456(81)90056-8.
6
Bias in treatment assignment in controlled clinical trials.
N Engl J Med. 1983 Dec 1;309(22):1358-61. doi: 10.1056/NEJM198312013092204.
7
A measure to aid in the interpretation of published clinical trials.一种有助于解读已发表临床试验的方法。
Stat Med. 1985 Jan-Mar;4(1):1-9. doi: 10.1002/sim.4780040103.
8
Meta-analysis in clinical trials.临床试验中的荟萃分析。
Control Clin Trials. 1986 Sep;7(3):177-88. doi: 10.1016/0197-2456(86)90046-2.
9
Meta-analysis in clinical research.临床研究中的荟萃分析。
Ann Intern Med. 1987 Aug;107(2):224-33. doi: 10.7326/0003-4819-107-2-224.
10
Publication bias in clinical research.临床研究中的发表偏倚。
Lancet. 1991 Apr 13;337(8746):867-72. doi: 10.1016/0140-6736(91)90201-y.
Zotero 插件